Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 60Neoplasms 58Lung Neoplasms 32Prostatic Neoplasms 24Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 21Neoplastic Cells, Circulating 20Head and Neck Neoplasms 19Pancreatic Neoplasms 17Melanoma 14Ovarian Neoplasms 13Carcinoma, Hepatocellular 12Esophageal Neoplasms 10Colonic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Glioma 9Squamous Cell Carcinoma of Head and Neck 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Sarcoma 7Neoplasm Metastasis 7Endometrial Neoplasms 7Stomach Neoplasms 6Neoplasm, Residual 6Myeloproliferative Disorders 6Leukemia 6Kidney Neoplasms 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6

Interventions

abemaciclib 2Blood Specimen Collection 2ribociclib 1palbociclib 1Watchful Waiting 1Surgical Procedures, Operative 1Letrozole 1Lead 1High-Energy Shock Waves 1Genotype 1Fulvestrant 1Bone Density 1Body Height 1Blood Pressure 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Breast Diseases × Blood Specimen Collection × Clear all
NCT07010939 2025-09-12

PERSEVERE

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
3,000 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT00842465 2013-11-25

Prolacsein

Assistance Publique - Hôpitaux de Paris

Completed
735 enrolled
Breast

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡